| FNDR-20123 |
---|---|
Plasma protein binding (% bound) | |
 Mouse/Rat/Dog/Monkey/Human | < 30.00/41.89/< 20.00/< 20.00/57.30 |
Microsomal stability (% remaining at 120Â min) | |
 MLM/RLM/HLM (Test Conc. 10 µM) | 76.15/74.56/85.31 |
Plasma stability | |
 Mouse/Rat/Dog/Human (% remaining at 240 min) | 89.16/88.90/97.72/98.94 |
CYP inhibition (IC50 µM) | |
 CYP 1A2 | > 60 |
 CYP 2C9 | > 60 |
 CYP 2C19 | > 60 |
 CYP 2D6 | 28.00 |
 CYP 3A4 | 27.00 |
CYP induction (% induction relative to respective positive controls) | |
 CYP 1A2 | 2.8 ± 0.8 |
 CYP 2B6 | 0.0 |
 CYP 3A4 | 0.9 ± 1.5 |
Cytotoxicity | |
 HepG2 (% @ 100 µM) | 12.6% |
 THP-1 (IC50 µM) | 113.6 µM |
hERG binding | |
 IC50 in µM | > 100 µM |